The Next Generation of Liquid Biopsy
We’re developing solutions to improve detection and characterization of cancer. Our transformative technologies, PointSuppressor™ and NexGenAbler™, deliver orders of magnitude improvements to sensitivity and scalability of cell-free DNA-based liquid biopsy to enable effective, non-invasive cancer screening and monitoring.